Showing results (41-50 of 102) with videos related to
Sort By:
Pageof 11
Molecular Cancer Therapeutics|June 3, 2010
Antitumor activity and immune response induction of a dual agonist of Toll-like receptors 7 and 8Daqing Wang, Melissa Precopio, Tao Lan, et al.Journal of Medicinal Chemistry|August 5, 2009
Modifications incorporated in CpG motifs of oligodeoxynucleotides lead to antagonist activity of toll-like receptors 7 and 9Dong Yu, Daqing Wang, Fu-Gang Zhu, et al.Nucleic Acids Research|February 12, 2013
Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9Ekambar R Kandimalla, Lakshmi Bhagat, Daqing Wang, et al.Nucleic Acids Research|October 18, 2002
'Immunomers'--novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agentsDong Yu, Ekambar R Kandimalla, Lakshmi Bhagat, et al.Journal of Medicinal Chemistry|September 20, 2002
Design, synthesis, and immunostimulatory properties of CpG DNAs containing alkyl-linker substitutions: role of nucleosides in the flanking sequencesDong Yu, Ekambar R Kandimalla, Yanping Cong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylationYee Sook Cho, Meyoung-Kon Kim, Langzhu Tan, et al.Biochemical and Biophysical Research Communications|September 11, 2002
Potent CpG oligonucleotides containing phosphodiester linkages: in vitro and in vivo immunostimulatory propertiesDong Yu, Fu-Gang Zhu, Lakshmi Bhagat, et al.Nucleic Acids Research|June 27, 2006
Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modificationsMallikarjuna Reddy Putta, FuGang Zhu, Yukui Li, et al.Plos One|June 6, 2012
An in situ autologous tumor vaccination with combined radiation therapy and TLR9 agonist therapyHuagang Zhang, Laibin Liu, Dong Yu, et al.International Immunopharmacology|February 21, 2004
Novel immunomodulatory oligonucleotides prevent development of allergic airway inflammation and airway hyperresponsiveness in asthmaDevendra K Agrawal, Jehad Edwan, Ekambar R Kandimalla, et al.Pageof 11